Home / Inspections / 1284680

FDA Inspection 1284680 — Pfizer, Inc.

Pfizer, Inc. — FEI 1211022

The FDA completed an inspection of Pfizer, Inc. on October 24, 2025 in Groton, CT. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
October 24, 2025
Fiscal Year
2026
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Groton, CT (United States)

Additional Details

Sponsor, Contract Research Organization

Facility

Other inspections at this facility

  • 1204434 (NAI Wed Apr 19 2023 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1190580 (NAI Fri Oct 28 2022 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1158313 (NAI Fri Nov 19 2021 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1143781 (NAI Fri Jun 04 2021 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1135196 (NAI Fri Jan 08 2021 00:00:00 GMT+0000 (Coordinated Universal Time))

Recent compliance actions

FDA data resources